The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial.
 
Luis G. Paz-Ares
Leadership - European Medicines Agency (I); Genomica
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Incyte; Lilly; Merck Serono; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sysmex
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca Spain; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Jose Manuel Trigo Perez
No Relationships to Disclose
 
Benjamin Besse
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Biogen (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Inivata (Inst); Ipsen (Inst); Lilly (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Nektar (Inst); Onxeo (Inst); Pfizer (Inst); PharmaMar (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Tiziana Therapeutics (Inst)
 
Victor Moreno
No Relationships to Disclose
 
Rafael Lopez
Stock and Other Ownership Interests - MTrap; Nasasbiotech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen; lilly; MSD; Roche
Speakers' Bureau - Novartis; Roche
Research Funding - Lilly (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pierre Fabre; Roche; Tesaro
 
Maria Angeles Sala
No Relationships to Disclose
 
Santiago Ponce Aix
No Relationships to Disclose
 
Cristian Marcelo Fernandez
Employment - PharmaMar
 
Mariano Siguero
Employment - PharmaMar
Honoraria - PharmaMar
 
Carmen Maria Kahatt
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Ali Hassan Zeaiter
Employment - PharmaMar
Leadership - PharmaMar
Stock and Other Ownership Interests - PharmaMar; SERVIER
Honoraria - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Khalil Zaman
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Eisai (Inst); Genomic Health (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Pfizer; Roche; Roche
 
Valentina Boni
No Relationships to Disclose
 
Jennifer Arrondeau
Travel, Accommodations, Expenses - Pfizer
 
Maite Martinez Aguillo
No Relationships to Disclose
 
Jean-Pierre Delord
No Relationships to Disclose
 
Ahmad Awada
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Leo Pharma; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Ipsen; Pfizer; Roche
 
Rebecca Sophie Kristeleit
Honoraria - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Consulting or Advisory Role - Basilea; Cerulean Pharma; Clovis Oncology; Roche/Genentech; Sotio
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; Valirx
 
Maria Eugenia Olmedo Garcia
No Relationships to Disclose
 
Vivek Subbiah
Consulting or Advisory Role - MedImmune
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Exelixis (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); Inhibrx (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Takeda (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; PharmaMar